Prescription Drug Marketing Act (PDMA)
From Wikipedia, the free encyclopedia
The Prescription Drug Marketing Act (PDMA) of 1987 (P.L. 100-293, 102 Stat. 95) is a law of the United States federal government. It establishes legal safeguards for prescription drug distribution to ensure safe and effective pharmaceuticals. It's designed to discourage the sale of counterfeit, adulterated, misbranded, subpotent, and expired prescription drugs. It was passed in response to the development of a wholesale sub-market (known as the "diversion market") for prescription drugs.
The PDMA was modified by the Prescription Drug Amendments of 1992 (P.L. 102-353, 106 Stat. 941) on August 26, 1992.
[edit] See also
- Regulation of therapeutic goods
- Good Distribution Practice
- Electronic pedigree
- Food and Drug Administration (FDA, USA)
[edit] External links
- U.S. Food and Drug Administration's Report to Congress, June 2001
- U.S. Food and Drug Administration's Report to Congress, June 2001 (PDF)
- California Department of Health Services Website, Food and Drug Branch page (State agency provides background on federal PDMA)
 |
This article is a stub relating to law in the United States. You can help Wikipedia by expanding it. |
